至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Optimal CD4 T cell priming after LPS-based adjuvanticity with CD134 costimulation relies on CXCL9 production.

J Leukoc Biol. 2017; 
Shinde P, Liu W, Ménoret A,, Luster AD, Vella AT.
Products/Services Used Details Operation
Peptide Synthesis … Louis, MO, USA) and 4 h later, immunized intraperitoneally with 100 μg Eα peptide (Thermo Fisher Scientific, Waltham, MA, USA, or GenScript, Piscataway, NJ, USA), 30 μg LPS (Salmonella typhimurium; Sigma‐Aldrich), and 7 μg anti‐CD134 mAb (Clone OX86; Bio X Cell), as … Get A Quote

摘要

LPS is a powerful adjuvant, and although LPS-mediated TLR4 signaling has been exquisitely delineated, the in vivo mechanism of how TLR4 responses impact T cell priming is far less clear. Besides costimulation, TNF and type 1 IFN are dominant cytokines released after TLR4 activation and can shape T cell responses, but other downstream factors have not been examined extensively. Depending on context, we show that IFNαR1 blockade resulted in minor to major effects on specific CD4 T cell clonal expansion. To help explain these differences, it was hypothesized that IFNαR1 blockade would inhibit specific T cell migration by reducing chemokine receptor signaling, but specific CD4 T cells from IFNαR1-blocked mice we... More

关键词

T cell expansion; TLR4; Type I IFN